In the age of digitization, telemedicine services are utilized more than ever, and this trend affects healthcare as well. Although the utilization of technology serves as a benefit in allowing more access to care, COVID-19 has identified some of the weaknesses and discrepancies of the system. The increase in usage of technology has shed light on and increased the severity of the gaps in the regulatory and legal infrastructure overseeing this rapid growth. We aim to evaluate the strengths and weaknesses of the telemedicine healthcare system, as well as address the frequent misconduct that occurs between patients and their nurses, pharmacists, and physician assistants, in order to highlight the necessity of a standardized method of reporting misconduct on an international, national, state, county, and local level. Our findings should alert the healthcare community of the growing urgency to address the policy and regulatory aspects of telemedicine to provide greater quality and safety during the post-COVID era.
Makary MA, Daniel M. Medical error—the third leading cause of death in the US. BMJ. 2016;i2139.
2.
Calton B, Abedini N, Fratkin M. Telemedicine in the Time of Coronavirus. Journal of Pain and Symptom Management. 2020;60(1):e12–4.
3.
10AD;
4.
Fauber J, Wynn M, Fiore K. Prescription for secrecy. Journal Sentinel Feb. 2018;
5.
American Nurses Association. State law and regulation. 10AD;
6.
American Association of Critical-Care Nurses. AACN TeleICU nursing consensus statement. 10AD;
7.
Zhou N, Lu H. A review and comparison of midwifery management and education in five representative countries. International Journal of Nursing Sciences. 2018;5(1):10–4.
8.
Advanced Practice Registered Nurses (APRN). 10AD;
9.
Oshodi TO, Bruneau B, Crockett R, Kinchington F, Nayar S, West E. Registered nurses’ perceptions and experiences of autonomy: a descriptive phenomenological study. BMC Nursing. 2019;18(1).
10.
COVID-19: recommendations for pursuing liability protections through state action. 10AD;
11.
Cenziper D, P. As nursing home residents died, new covid-19 protections shielded companies from lawsuits. Families say that hides the truth. The Washington Post. WP Company. 2020;
12.
Werner RM, Hoffman AK, Coe NB. Long-Term Care Policy after Covid-19 — Solving the Nursing Home Crisis. New England Journal of Medicine. 2020;383(10):903–5.
13.
Tariq R, Scherbak Y. Medication errors. StatPearls Treasure Island. 2020;
14.
Björkstén KS, Bergqvist M, Andersén-Karlsson E, Benson L, Ulfvarson J. Medication errors as malpractice-a qualitative content analysis of 585 medication errors by nurses in Sweden. BMC Health Services Research. 2016;16(1).
15.
Rodziewicz T, Hipskind J. Medical error prevention. StatPearls Treasure Island. 2020;
16.
Shachar C, Engel J, Elwyn G. Implications for Telehealth in a Postpandemic Future. JAMA. 2020;323(23):2375.
17.
AMA adopts new guidance for ethical practice in telemedicine. 10AD;
18.
Rimsza ME, Hotaling AJ, Keown ME, Marcin JP, Moskowitz WB, et al. The Use of Telemedicine to Address Access and Physician Workforce Shortages. Pediatrics. 2015;136(1):202–9.
19.
Brown C, Houston Medical M, Lawyer. Texas and Louisiana Medical Malpractice Firm. 2020;
20.
American Academy of Physician Assistants. The case for separate PA regulatory boards. 10AD;
21.
Berkowitz O. Physician Assistants Policy and Practice, 4th Edition. Journal of Physician Assistant Education. 2018;29(4):237–8.
22.
Physician assistant scope of practice. 10AD;
23.
Establishes certain requirements to use telemedicine and telehealth to respond to coronavirus disease 2019 (COVID-19). S A3860 The General Assembly of the State of New Jersey 2020-2021. 10AD;
24.
Pharmacist Conscience clauses: laws and information. 10AD;
25.
10AD;
26.
U. Food and Drug Administration. Guidance compliance, and regulatory information. 10AD;
27.
Drugs of Abuse: A DEA Resource Guide. 2017;
28.
10AD;
29.
10AD;
30.
Panagioti M, Khan K, Keers RN, Abuzour A, Phipps D, Kontopantelis E, et al. Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis. BMJ. 2019;l4185.
31.
Mass, Gov. Interstate prescription data sharing. 10AD;
32.
Prescription drug monitoring programs (PDMPs). 10AD;
33.
Prescription drug monitoring programs: state-by state overview. 10AD;
34.
10AD;
35.
Wal-Mart F, Inc. 2019;
36.
Taylor AM, Bingham J, Schussel K, Axon DR, Dickman DJ, Boesen K, et al. Integrating Innovative Telehealth Solutions into an Interprofessional Team-Delivered Chronic Care Management Pilot Program. Journal of Managed Care & Specialty Pharmacy. 2018;24(8):813–8.
37.
Eid D, Osborne J, Borowicz B. Moving the Needle: A 50-State and District of Columbia Landscape Review of Laws Regarding Pharmacy Technician Vaccine Administration. Pharmacy. 2019;7(4):168.
38.
Reiner G, Pierce SL, Flynn J. Wrong drug and wrong dose dispensing errors identified in pharmacist professional liability claims. Journal of the American Pharmacists Association. 2020;60(5):e50–6.
39.
Bashshur R, Doarn CR, Frenk JM, Kvedar JC, Woolliscroft JO. Telemedicine and the COVID-19 Pandemic, Lessons for the Future. Telemedicine and e-Health. 2020;26(5):571–3.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
